<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
--
ENERGY BIOSYSTEMS CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.01 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
29265L-10-2
----------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
Page 1 of 10
<PAGE>
SCHEDULE 13G
CUSIP No. 29265L-10-2 Page 2 of 10
----------- --- ---
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person
Gryphon Ventures II, Limited Partnership
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Massachusetts
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 0
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With: 305,154
--------------------------------------------------
(7) Sole Dispositive Power
0
--------------------------------------------------
(8) Shared Dispositive Power
305,154
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
305,154
- -------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares* /X/
157,635 shares that Ethyl Corporation may acquire upon conversion
of 160,000 shares of Series B Convertible Preferred Stock of the
Issuer.
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
4.64%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE,
RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF
THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 2 of 10
<PAGE>
SCHEDULE 13G
CUSIP No. 29265L-10-2 Page 3 of 10
----------- --- ---
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person
Gryphon Financial Partners II
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Massachusetts
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 0
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With: 305,154
--------------------------------------------------
(7) Sole Dispositive Power
0
--------------------------------------------------
(8) Shared Dispositive Power
305,154
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
305,154
- -------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares* /X/
157,635 shares that Ethyl Corporation may acquire upon conversion
of 160,000 shares of Series B Convertible Preferred Stock of the
Issuer.
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
4.64%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE,
RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF
THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 3 of 10
<PAGE>
SCHEDULE 13G
CUSIP No. 29265L-10-2 Page 4 of 10
----------- --- ---
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person
Edward B. Lurier
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
U.S.
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 5,713
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With: 305,439
--------------------------------------------------
(7) Sole Dispositive Power
5,713
--------------------------------------------------
(8) Shared Dispositive Power
305,439
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
311,152
- -------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares* /X/
157,635 shares that Ethyl Corporation may acquire upon conversion
of 160,000 shares of Series B Convertible Preferred Stock of the
Issuer.
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
4.74%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE,
RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF
THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 4 of 10
<PAGE>
SCHEDULE 13G
CUSIP No. 29265L-10-2 Page 5 of 10
----------- --- ---
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person
William F. Aikman
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
U.S.
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 357
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With: 305,154
--------------------------------------------------
(7) Sole Dispositive Power
357
--------------------------------------------------
(8) Shared Dispositive Power
305,154
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
305,511
- -------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares* /X/
157,635 shares that Ethyl Corporation may acquire upon conversion
of 160,000 shares of Series B Convertible Preferred Stock of the
Issuer.
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
4.65%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE,
RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF
THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 5 of 10
<PAGE>
ITEM 1.
(a) Name of Issuer
Energy BioSystems Corporation.
---------------------------------------------------------------------
(b) Address of Issuer's Principal Executive Offices
3608 Research Forest Drive, The Woodlands, Texas 77381.
---------------------------------------------------------------------
ITEM 2.
(a) Name of Person Filing:
Gryphon Ventures II, Limited Partnership, Gryphon Financial
Partners II, Edward B. Lurier and William F. Aikman
(collectively, the "Reporting Persons"). This Schedule 13G is
being filed on behalf of Gryphon Financial Partners II because
it is the general partner of Gryphon Ventures II, Limited
Partnership, and is being filed on behalf of Messrs. Lurier
and Aikman because each of them is a general partner of
Gryphon Financial Partners II.
---------------------------------------------------------------------
(b) Address of Principal Business Office:
The address of each of the Reporting Persons is 222 Berkeley
Street, Suite 1600, Boston, Massachusetts 02116.
---------------------------------------------------------------------
(c) Citizenship
Not applicable as to Gryphon Ventures II, Limited Partnership and
Gryphon Financial Partners II. Messrs. Lurier and Aikman are
citizens of the United States.
---------------------------------------------------------------------
(d) Title of Class of Securities: Common Stock, par value $.01 per share
---------------------------------------------------------------------
(e) CUSIP Number: 29265L-10-2
---------------------------------------------------------------------
ITEM 3. Not applicable.
ITEM 4. OWNERSHIP
(a) Amount beneficially owned: As of December 31, 1999, (i)
Gryphon Ventures II, Limited Partnership was the record and
beneficial owner of 305,154 shares of Common Stock (the
"Subject Shares") of the Issuer, (ii) Mr. Lurier was the
record and beneficial owner of 5,713 shares of Common Stock of
the Issuer and (iii) Mr. Aikman was the record and beneficial
owner of 357 shares of Common Stock of the Issuer. Under Rule
13d-3 promulgated pursuant to the Securities Exchange Act of
1934, as amended, (i) Gryphon
Page 6 of 10
<PAGE>
Financial Partners II and Messrs. Lurier and Aikman may each
be deemed to have beneficially owned the Subject Shares and
(ii) Mr. Lurier may be deemed to have beneficially owned 285
shares of Common Stock of the Issues owned (of record and
beneficially) by his wife, Joan Lurier (the "Joan Lurier
Shares"). The filing of this Schedule 13G on behalf of Gryphon
Financial Partners II and each of Messrs. Lurier and Aikman
shall not be construed as an admission that (i) any of such
persons beneficially owned the Subject Shares or (ii) Mr.
Lurier beneficially owned the Joan Lurier Shares. Such
beneficial ownership is hereby disclaimed.
(b) Percent of Class: As of December 31, 1999, Gryphon
Ventures II, Limited Partnership and Gryphon Financial
Partners II and Mr. Aikman each beneficially owned or may be
deemed to have beneficially owned 4.64% of the class. As of
December 31, 1999, Mr. Lurier beneficially owned or may be
deemed to have beneficially owned 4.74% of the class.
(c) As of December 31, 1999, the Reporting Persons may be
deemed to have had shared power to vote or to direct the vote
of, and to dispose or to direct the disposition of, the
Subject Shares. As of December 31, 1999, Mr. Lurier (i) had
sole power to vote or direct the vote, and to dispose or to
direct the disposition, of the 5,713 shares of Common Stock he
owned individually and (ii) may be deemed to have had shared
power to vote or to direct the vote of, and to dispose or to
direct the disposition of the Joan Lurier Shares. As of
December 31, 1999, Mr. Aikman had sole power to vote or to
direct the vote, and to dispose or to direct the disposition,
of the 357 shares of Common Stock he owned individually.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following |X|.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
The limited partner of Gryphon Ventures II, Limited
Partnership, Ethyl Ventures, Inc., has the right to receive
proceeds from the sale of the Subject Shares. Ethyl Ventures,
Inc. is a wholly-owned subsidiary of Ethyl Corporation, a
Virginia corporation ("Ethyl"), which as reported on Ethyl's
Schedule 13D, dated October 27, 1994, as amended by filings
dated March 23, 1995 and April 13, 1995, has beneficial
ownership of 157,635 shares of Common Stock of the Issuer that
Ethyl may acquire upon conversion of its 160,000 shares of
Series B Convertible Preferred Stock of the Issuer.
Page 7 of 10
<PAGE>
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
Page 8 of 10
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
GRYPHON VENTURES II, LIMITED
PARTNERSHIP
By Gryphon Financial Partners II,
General Partner
By /s/ William F. Aikman
------------------------------------------
William F. Aikman, General Partner
Date: February 1, 2000
/s/ Edward B. Lurier
-------------------------------------------
Edward B. Lurier
Date: February 1, 2000
/s/ William F. Aikman
-------------------------------------------
William F. Aikman
Date: February 1, 2000
GRYPHON FINANCIAL PARTNERS II
By /s/ William F. Aikman
-----------------------------------------
William F. Aikman, General Partner
Date: February 1, 2000
Page 9 of 10
<PAGE>
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned agree that the statement on Schedule 13G to which
this Joint Filing Agreement is attached is filed on behalf of each of them.
GRYPHON VENTURES II, LIMITED
PARTNERSHIP
By Gryphon Financial Partners II,
General Partner
By /s/ William F. Aikman
---------------------------------------------
William F. Aikman, General Partner
/s/ Edward B. Lurier
------------------------------------------------
Edward B. Lurier
/s/ William F. Aikman
------------------------------------------------
William F. Aikman
GRYPHON FINANCIAL PARTNERS II
By /s/ William F. Aikman
---------------------------------------------
William F. Aikman, General Partner
Dated: February 1, 2000
Page 10 of 10
